These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6494383)

  • 1. Serum aldosterone following dexamethasone in depressed patients.
    Targum SD; White ME; Collins-Rothe H; Sullivan P
    Psychoneuroendocrinology; 1984; 9(3):305-9. PubMed ID: 6494383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dexamethasone suppression test in depressed retarded adults: preliminary findings.
    Beckwith BE; Parker L; Pawlarczyk D; Couk DI; Schumacher KS; Yearwood K
    Biol Psychiatry; 1985 Aug; 20(8):825-31. PubMed ID: 4027299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noradrenergic function and the cortisol response to dexamethasone in depression.
    Rubin AL; Price LH; Charney DS; Heninger GR
    Psychiatry Res; 1985 May; 15(1):5-15. PubMed ID: 2989963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of weight loss on the dexamethasone suppression test.
    Yerevanian BI; Baciewicz GJ; Iker HP; Privitera MR
    Psychiatry Res; 1984 Jun; 12(2):155-60. PubMed ID: 6591220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reported weight loss and dexamethasone nonsuppression in depressed patients. A negative study.
    Gwirtsman HE; Roy-Byrne P; Gitlin MJ; Halaris A; Ahles S
    J Affect Disord; 1985 Sep; 9(2):193-6. PubMed ID: 2932495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisol.
    Halbreich U; Naor S; Asnis G; Gasparini F; Goldstein S; Vital-Herne J; Kang BJ
    Biol Psychiatry; 1986 Dec; 21(14):1434-7. PubMed ID: 3790627
    [No Abstract]   [Full Text] [Related]  

  • 7. Major depressive episode and low dose dexamethasone suppression test.
    Sarai M; Taniguchi N; Kagomoto T; Kameda H; Uema T; Hishikawa Y
    Folia Psychiatr Neurol Jpn; 1982; 36(2):109-14. PubMed ID: 7129257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine interrelationships in major depressive disorder.
    Targum SD; Sullivan AC; Byrnes SM
    Am J Psychiatry; 1982 Mar; 139(3):282-6. PubMed ID: 6800269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
    Kathol RG; Jaeckle RS; Lopez JF; Meller WH
    Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dexamethasone suppression test in depressed and non-depressed geriatric medical inpatients.
    Magni G; Schifano F; De Leo D; De Dominicis MG; Garbin A; Zangaglia O
    Acta Psychiatr Scand; 1986 May; 73(5):511-4. PubMed ID: 3751656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
    Coccaro EF; Prudic J; Rothpearl A; Nurnberg HG
    J Affect Disord; 1985 Sep; 9(2):107-13. PubMed ID: 2932482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone suppression and metyrapone tests in depression.
    Morphy MA; Fava GA; Perini GI; Molnar G; Zielezny M; Lisansky J
    Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
    Lemus CZ; Asnis GM; Halbreich U; Harkavy Friedman JM; Van Praag HM; Rubinson E; Eisenberg J
    J Affect Disord; 1987; 12(3):219-21. PubMed ID: 2956306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and the dexamethasone suppression test: results from a broad unselected patient population.
    Keitner GI; Ryan CE; Kohn R; Miller IW; Norman WH; Brown WA
    Psychiatry Res; 1992 Oct; 44(1):9-20. PubMed ID: 1461951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of hypothalamic-pituitary-adrenal axis function in depressed alcoholic patients.
    Targum SD; Wheadon DE; Chastek CT; McCabe WJ; Advani MT
    J Affect Disord; 1982 Dec; 4(4):347-53. PubMed ID: 6219148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisol.
    Gerken A; Holsboer F
    Psychoneuroendocrinology; 1986; 11(2):185-94. PubMed ID: 3018821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the dexamethasone suppression test with DSM-III criteria in psychiatrically hospitalized adolescents.
    Evans DL; Nemeroff CB; Haggerty JJ; Pedersen CA
    Psychoneuroendocrinology; 1987; 12(3):203-9. PubMed ID: 3615749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone suppression test and sleep deprivation in endogenous depression.
    Kuhs H
    J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.